Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Rental Rate Antitrust Lawsuit
    • Automobile 3G Network Shutdown Lawsuit
    • Similac Toxic Infant Formula Lawsuit
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
  • Rental Rate Antitrust Lawsuit
  • Automobile 3G Network Shutdown Lawsuit
  • Similac Toxic Infant Formula Lawsuit
  • Kid’s Castle Biometric Privacy Lawsuit
  • Contaminated Baby Food Lawsuit
  • Fatal Sportmix Pet Food Recall Class Action Lawsuit
  • Claire’s Data Breach Lawsuit
  • Insurance Denial for Mental Health and Substance Abuse Treatment
  • Perpetual Sales Litigation
  • Railroad Price-Fixing Lawsuit
  • Medicare Advantage Fraud Litigation
  • Biometric Fingerprinting Litigation

Insurance Denial for Mental Health and Substance Abuse Treatment

Seeking help for a mental health or substance abuse problem can be an extremely challenging decision to make. Seeking help can be even more difficult when insurance providers deny coverage for treatment. Despite well-established generally standards of medical care – countless patients have found it frustrating – if not outright impossible – to secure mental health and addiction treatment coverage.

Drug and alcohol dependency are major risk factors that affect the health and wellbeing of millions of Americans. Sadly, 67,000 Americans died from opioid addiction in 2018 alone, while countless more struggled with addictions to other substances and mental health disorders. But despite the necessity and availability of treatment programs, many insurance providers deny coverage or fail to fully cover treatment that could mean the difference between life and death.

Why Do Insurers Deny Mental Health and Substance Abuse Coverage?

While insurers typically base coverage decisions on a case-by-case basis determined by their customer’s insurance plans, many who have been denied mental health and substance abuse coverage have reported similar rejections regardless of the insurer or policy.

Lack of “Medical Necessity”

One of the most common reasons insurers refuse to cover mental health and substance abuse treatment is because of a supposed lack of medical necessity. According to the insurers, because the policyholder’s addiction does not constitute an immediate need for lifesaving care, their treatment does not qualify for coverage. Disregarding the fact that mental health and substance abuse disorders are often chronic, the insurers may outright exclude, set arbitrary treatment limits, and refuse to pay for residential treatment for mental health and substance abuse disorder.  In the case of substance abuse disorders, insurers may also refuse to cover or limit coverage for medication assisted treatment (“MAT”) and toxicology tests.

Limiting the Duration and Degree of Residential Treatment

The generally accepted standards of treatment for mental health and substance abused disorders are readily available to insurance carriers.  But insurers may not always follow those standards.  Instead, insurers are imposing more restrictive standards and telling patients they are covered only for outpatient care when they need residential treatment.  Some insurers may not cover needed residential treatment at all.

Limiting the Duration and Degree of Care of Medication Assisted Treatment

Substance abuse treatment can be a long and extensive process. For many addictions, such as opioid dependency, the standard of care says a person will need lifelong care that includes carefully monitored alternatives like methadone. Because of the cost over time, many insurers will deny coverage outright or set improper limits on drug dosage limits, duration of treatment they will cover, or include caveats like refusing to cover additional treatments if the patient fails a drug test.

Limiting or Refusing to Cover Toxicology Testing Required for Medication Assisted Treatment

MAT Treatment providers are required to administer onsite toxicology screening for patients battling opioid addiction. The industry standard testing is 99% accurate, which is essential so physicians can properly administer care to their patients. However, many insurance providers will only pay for much cheaper testing that may only identify the type of drugs a patient is on 50% of the time. This substandard testing may not show the full extent of a patient’s need for substance abuse treatment, giving the insurer cover to deny coverage due to a lack of need.

What Can You Do if Coverage for Your Mental Health or Substance Abuse Treatment is Denied?

 

Unfortunately for people seeking treatment for substance abuse, they are often at the mercy – or lack thereof – of their insurance provider. Insurers have been making it increasingly more difficult for customers to seek treatment for chemical dependency and mental health issues. And while it is possible to file an appeal with your insurance provider, the process can be lengthy and cumbersome. Even then, there is no guarantee the insurer will agree to cover your treatment plan.

Wexler Boley & Elgersma is currently investigating claims of insurance companies that disregard the applicable medical standards of care and set narrower coverage standards for mental health and substance abuse treatment. If your treatment was improperly denied by an insurance company, you may have grounds to take legal action. Contact our attorneys today and discuss your potential claim.

  • Facebook
  • Twitter
  • LinkedIn
Image

311 S. Wacker Drive,
Suite 5450
Chicago, IL 60606
P_312.346.2222
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2023 © Wexler Boley & Elgersma LLP

Wexler Boley & Elgersma uses cookies to improve the performance and functionality of this site. By using our website, you are providing us with your consent to use cookies on this site. Close Privacy Policy
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT